APA

Litton J. K., Scoggins M., Ramirez D. L., Murthy R. K., Whitman G. J., Hess K. R., Adrada B. E., Moulder S. L., Barcenas C. H., Valero V., Gomez J. S., Mittendorf E. A., Thompson A., Helgason T., Mills G. B., Piwnica-Worms H. & Arun B. K. (2017). A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline. : NPJ breast cancer.

Chicago

Litton J K, Scoggins M, Ramirez D L, Murthy R K, Whitman G J, Hess K R, Adrada B E, Moulder S L, Barcenas C H, Valero V, Gomez J Schwartz, Mittendorf E A, Thompson A, Helgason T, Mills G B, Piwnica-Worms H and Arun B K. 2017. A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline. : NPJ breast cancer.

Harvard

Litton J. K., Scoggins M., Ramirez D. L., Murthy R. K., Whitman G. J., Hess K. R., Adrada B. E., Moulder S. L., Barcenas C. H., Valero V., Gomez J. S., Mittendorf E. A., Thompson A., Helgason T., Mills G. B., Piwnica-Worms H. and Arun B. K. (2017). A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline. : NPJ breast cancer.

MLA

Litton J K, Scoggins M, Ramirez D L, Murthy R K, Whitman G J, Hess K R, Adrada B E, Moulder S L, Barcenas C H, Valero V, Gomez J Schwartz, Mittendorf E A, Thompson A, Helgason T, Mills G B, Piwnica-Worms H and Arun B K. A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline. : NPJ breast cancer. 2017.